DCM
GWPH

Diag Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Diag Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$1.31M Buy
+13,460
New +$1.77M 1.5% 26

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diag Capital Management's GWPH Position: Q4 2018 in Review

Diag Capital Management opened a new position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2018: 13,460 shares worth $1.31M. The stake represents 1.5% of the portfolio and ranks #26 among its holdings.

277 funds tracked by Wall St. Rank hold GWPH as of Q4 2018.

  • Diag Capital Management held 13,460 shares of GW Pharmaceuticals Plc American Depositary Shares worth $1.31M as of Q4 2018.
  • GW Pharmaceuticals Plc American Depositary Shares was a new Diag Capital Management position in Q4 2018.
  • GW Pharmaceuticals Plc American Depositary Shares made up 1.5% of Diag Capital Management's portfolio in Q4 2018, its #26 holding.
  • 277 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2018.

Based on Diag Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.